Andrea D’Amato has been appointed as the new manager of Gsk’s site in Rosia, which is a global center for the production of bacterial vaccines. He replaces Maria Chiara Amadei, who has taken on a global role within the company as the head of secondary production for GSK Vaccines. D’Amato has a background in chemistry and pharmaceutical technology and has worked for Merck, holding positions of increasing responsibility in both the Italian and global sites. He most recently led Merck’s Biotech Campus in Switzerland, which employs around 1,000 people. D’Amato expressed his pride in taking on this role and sees it as a stimulating challenge with great responsibility. He highlighted the strategic importance of the Rosia site within the GSK network, particularly in the production of key vaccines. He also mentioned the site’s role in combating meningococcal meningitis through research, production, and distribution. D’Amato believes that the site has all the necessary ingredients for success, including the right skills, a stimulating environment, and significant investments to enhance infrastructure and production lines. He is optimistic about the site’s future prospects and is eager to begin his role with enthusiasm, humility, and a desire to achieve the company’s goals.
Gsk, Andrea D’amato guiderà il sito produttivo di Rosia – Siena News
Siena Andrea D'amato sarà il nuovo responsabile del sito produttivo di Rosia per Gsk. GN